{"database": "lobbying", "table": "lobbying_activities", "rows": [[2463222, "97718ff3-7360-4fb9-8642-f70e2cbaf5e3", "Q2", "REINECKE STRATEGIC SOLUTIONS, INC.", 298012, "PHARMAVITE LLC", 2020, "second_quarter", "FOO", "FY2021 Adequate Food and Drug Administration funding for regulation of dietary supplements and oversight of CBD products (no bill number).  Support for mandatory dietary supplement product registry. (no legislation)  Support for regulatory pathway for quality hemp-derived products. Support for legislation (S.1717/H.R. 3142) to give SNAP recipients the choice to purchase multi-vitamins to supplement their diet. Support for inclusion of dietary supplement costs as allowable HSA and FSA expenses.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2020-07-10T10:12:25.940000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2463222"], "units": {}, "query_ms": 0.31420309096574783, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}